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Background: Minimally invasive esophagectomy theoretically offers advantages compared with open 
esophagectomy (OE). The aim of this study was to compare the early- and mid-term outcomes between 
video-assisted thoracoscopic surgery (VATS) esophagectomy (VE) and OE in patients with esophageal 
cancer.
Methods: Between November 2011 and July 2015, a total of 172 patients were divided into two groups 
depending on the method of esophagectomy: the VE group (n=42) and the OE group (n=130). A propensity 
analysis that incorporated perioperative variables, such as age, sex, preoperative pulmonary function, 
Charlson comorbidity index, tumor location, histologic grade of the tumor, pathologic stage and operative 
procedure (Ivor Lewis or McKeown) was performed, and postoperative outcomes were compared.
Results: Matching based on propensity scores produced 42 patients in each group for the analysis. 
After propensity matching, there were only two operative mortalities in the OE group, and both died of 
postoperative pneumonia. The overall incidence of postoperative complications was 38.1% (16 of 42) and 
57.1% (24 of 42) in the VE group and in the OE group, respectively (P=0.088). The incidence of pulmonary 
complications was lower in the VE group than in the OE group (9.5% vs. 40.5%, P=0.004). The 2-year 
overall survival and disease-free survival were not different between the two groups (74.4% and 69.5% in the 
VE group, 69.5% and 69.8% in the OE group, P=0.865 and P=0.513, respectively).
Conclusions: In select patients, superior short-term surgical results and equal oncological outcomes were 
achieved with VE compared with OE.
Keywords: Esophageal cancer; minimally invasive esophagectomy (MIE); open esophagectomy (OE); pulmonary 
complication
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Introduction
Esophageal cancer is the 8th most common malignancy 
and the 6th most common cause of cancer-related 
death worldwide (1). Despite recent advancements in 
multidisciplinary approaches, surgical resection is still the 
mainstay treatment for potentially resectable esophageal 
cancer (2). However, esophageal cancer surgery remains to 
have high postoperative morbidity and mortality. This is 
most likely associated with extensive and aggressive surgical 
procedures (2-5). 
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Traditionally, esophageal cancer has been surgically 
treated with esophagectomy via open thoracotomy, or 
simply, open esophagectomy (OE). Moreover, esophageal 
cancer requiring esophagectomy is more prevalent 
in elderly patients with numerous comorbidities. To 
reduce the physiologic stress and morbidities associated 
with OE, minimally invasive esophagectomy (MIE) has 
been recognized to be important (6). With improved 
instrumentation as well as increased exposure and experience 
using endoscopic surgical techniques, the demand for 
minimally invasive surgical approaches, like MIE, for the 
resection of esophageal cancer is increasing. Accordingly, 
there has recently been a movement to determine the 
feasibility, postoperative results, and potential advantages of 
minimally invasive approaches. MIE, compared with OE, 
theoretically offers advantages, such as decreased morbidity, 
shorter hospital stay, and more rapid return to daily 
activities (7). Since several techniques are considered to be 
MIE (thoracoscopic, laparoscopic, mediastinoscopic, hybrid, 
total, and robotic-assisted MIE, etc.), it would be inaccurate 
to compare just MIE and OE. Our study focuses on video-
assisted thoracoscopic surgery (VATS) esophagectomy (VE) 
with left lateral decubitus position, which is a more familiar 
and widely utilized procedure to thoracic surgeons. 
Thus, the aim of this study was to compare the early- 
and mid-term operative outcomes between VE and OE in 
patients with esophageal cancer. 
Methods
Patients and clinical data
We retrospectively analyzed the medical records of 
consecutive 220 patients who underwent esophagectomy 
and reconstruction with a stomach conduit in our 
institution for esophageal cancer between November 
2011 and July 2015. We excluded patients with clinical 
T4 esophageal cancer (n=7), those with upper thoracic 
esophageal cancer (n=36), and those who underwent 
neoadjuvant treatment (n=11; Figure 1). The data were 
collected by manual review of patients’ electronic medical 
records, which consisted of information on preoperative 
patient characteristics, disease status, operative procedures, 
pathologic report, and postoperative outcomes. Patients 
were staged using the American Joint Committee on 
Cancer (AJCC) 7th edition TNM staging system. Each 
patient underwent esophagogastroduodenoscopy (EGD) 
with biopsy, endoscopic ultrasonography, chest and 
abdominal computed tomography (CT), bronchoscopy, 
and 18F-fluorodeoxyglucose positron emitted tomography 
(FDG-PET)/CT to determine preoperative staging. 
Middle thoracic esophageal cancer was defined as a tumor 
located 25–30 cm from the incisors, and lower thoracic 
esophageal cancer was defined as a tumor located 31 cm to 
the gastro-esophageal junction. This retrospective study 
was approved by the local Institutional Review Board at the 
National Cancer Center Korea (No. 2017-0177), and the 
requirement for informed patient consent was waived due 
to the retrospective nature of this study.
Surgical approach
All  patients  were intubated with a double-lumen 
endotracheal tube. During the thoracic procedures, patients 
were positioned in the left lateral decubitus position, and 
the right lung was collapsed. In the VE operation, thoracic 
procedures were performed under VATS. Two ports and 
one working window were created [11-mm trocar: the 
camera was inserted 8th intercostal space (ICS) on the 
mid axillary line; 5-mm trocar: 6th ICS on the posterior 
axillary line for instrument; a 4-cm mini-thoracotomy was 
made in the 4th ICS applying wound protector between the 
anterior and mid axillary line]. Esophageal dissection and 
mobilization were performed in the same manner as the OE 
technique. All patients underwent total mediastinal lymph 
nodes dissection. A 3-field lymph node dissection (3-FD) 
was added for patients with middle thoracic esophageal 
cancer near the carina (8).
The azygos vein was divided with an endoscopic stapler. 
The thoracic duct was preserved unless in the event of 
direct tumor invasion or injury during esophageal or 
lymph node dissection. In Ivor Lewis procedure, after 
complete dissection between the membranous trachea 
and upper portion of the esophagus, intrathoracic 
esophagogastrostomy were performed using the whole 
stomach as a conduit, and anastomosis was performed with 
an end-to-end anastomosis stapler (EEA stapler; Autosuture, 
U.S. Surgical Corp., Norwalk, CT, USA). In the McKeown 
procedure, the gastric tube was created using 75-mm and 
55-mm TLC (Ethicon Ltd., Somerville, NJ, USA) staplers, 
and the conduit was pulled up gently through the posterior 
mediastinum and the cervical anastomosis was performed 
with an EEA stapler on the left side of the neck. 
The abdominal procedure was performed with an 
upper median laparotomy. The stomach was dissected 
free with preservation of the right gastroepiploic vessels. 
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After gastric mobilization for conduit, complete abdominal 
lymphadenectomy including the celiac axis, common 
hepatic, left gastric and distal esophagus was performed. 
A pyloroplasty was conducted with the finger-fracture 
method. The Kocher maneuver is normally not performed 
at our institution on a routine basis. 
Perioperative management
In the initial stage, VE was indicated for patients who did not 
have any pleural adhesion and was not considered to be in the 
advanced stages of esophageal cancer. However, during the 
study period, indications for VE were gradually expanded to 
include all patients who this procedure was thought possible. 
After the operations, all patients underwent EGD and 
esophagography on postoperative days 6 and 7 consecutively. 
They were typically allowed to take sips of water after 
confirming no leakage and conduit problems, and full liquid 
diet was implemented on the following day. If they were able 
to tolerate a liquid diet, soft foods were given.
Postoperative outcomes 
The postoperative outcomes of interests were operative 
mortality, overall and pulmonary complications, length of 
ICU stay, number of harvested lymph nodes, operation 
time, blood loss, and overall survival. Operative mortality 
was defined as any death occurring at any time during 
the same postoperative hospital stay or within 30 days of 
operation. We decided on the postoperative management 
plan by one team through mortality and morbidity 
conference every week. Postoperative complications 
included recurrent laryngeal nerve injury, pulmonary 
complications, arrhythmia, anastomotic leak or any 
conduit problem, chylothorax and postoperative bleeding. 
Postoperative pulmonary complications included atelectasis 
with sputum retention that required bronchoalveolar 
toileting using flexible bronchoscopy, postoperative 
pneumonia and either acute lung injury (ALI) or acute 
respiratory distress syndrome (ARDS). Postoperative 
pneumonia was defined by radiographic infiltration shadows 
with at least two of the following: temperature >37.7 ℃, 
white blood cell count >10,000/mm3 and positive sputum 
culture. Recurrent laryngeal nerve injury was diagnosed 
by an evaluation of the vocal cord mobility with a flexible 
laryngoscopy by an otolaryngologist. 
Follow-up
A follow-up was conducted every 3 months during the first 
2 years, then biannually from the 2nd to the 5th year and 
then annually thereafter. Chest CT was performed on these 
occasions, and an annual examination with FDG-PET/
CT and EGD was simultaneously conducted. The date 
of recurrence was defined as the date of the examination 
during which recurrence was documented. 
Statistical analysis
Clinicopathological features, including age, gender, 
body mass index, forced expiratory volume in 1 second 
(FEV1%), Charlson comorbidity index, tumor location, 
tumor type, tumor grade, pathologic T stage, pathologic 
N stage, operation method and 3-field dissection were 
compared between the VE group and the OE group. 
Thus, its influence on postoperative outcomes was also 
analyzed. Descriptive statistics were used to compare the 
variables between the two groups, using χ2 test or Fisher 
exact test for categorical variables and Student’s t-test 
for continuous variables. To control for the potential 
differences in the baseline characteristics of patients treated 
with VE or OE, propensity score was utilized. By using a 
multivariate logistic regression model, which included all 
clinicopathological features, the propensity scores were 
computed as the conditional probability of receiving either 
VE or OE. Using the Greedy 81-digit match algorithm, 
Figure 1 Flow diagram of exclusion criteria used for patient 
selection. Six patients were duplicated, 4 patients had neoadjuvant 
treatment with upper esophageal cancer and 2 patients were upper 
esophageal cancer with pT4. VATS, video-assisted thoracoscopic 
surgery.
Nov 2011 – Jul 2015
Surgery for esophageal cancer (N=220)
Exclusion
(I) pT4 or Stage IV (n=7)
(II) Upper esophageal cancer (n=36)






Produced 42 patients in each group
Propensity score analysis
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we created propensity score-matched pairs without 
replacement (a 1:1 match). Comparisons between the 
matched groups were performed with McNemar’s test for 
categorical variables and paired t-test or Wilcoxon rank 
sum test for continuous variables. Disease-free intervals and 
overall survival rates were determined using the Kaplan-
Meier method, and survival curves were compared with 
log-rank tests. All statistical analyses were performed using 
STATA 11.0 software (StataCorp., College Station, TX, 
USA). A two-sided P value of <0.05 was considered to be 
statistically significant.
Results
Between November 2011 and July 2015, a total of 172 
patients who met the inclusion criteria underwent esophageal 
resection and reconstruction with stomach conduit in 
our institution. The enrolled study patients were divided 
into two groups: The VE group (n=42), which included 
patients who underwent MIE with VATS and the OE 
group (n=130), which included patients who underwent 
conventional esophagectomy with open thoracotomy. The 
baseline characteristics of 172 patients are summarized in 
Table 1. There were substantial differences between the 
two groups. Patients in the VE group presented more 
frequently with a middle thoracic esophageal cancer and 
patients in the OE group presented more frequently with 
advanced T stage. To obtain more reliable outcomes, 
matching based on propensity scores produced 42 patients 
in each group; the paired groups were well balanced 
(Table 2). The P values were recalculated and there 
were no significant differences between the two groups. 
Postoperative outcomes are reported in Table 3. In the 
unadjusted data, there were no operative mortalities in the 
VE group, whereas there were five operative mortalities in 
the OE group; this difference was not statistically significant. 
Postoperative complications occurred in 16 patients (38.1%) 
in the VE group and 62 patients (47.7%) in the OE group 
(P=0.277). Pulmonary complications occurred more 
frequently in the OE group (29.2%) than in the VE group 
(9.5%, P=0.010). There were no differences between the 
groups with respect to other specific complications. However, 
the operation time was longer in the VE group (P=0.025), 
and the number of harvested lymph nodes detected were 
greater in the OE group (P=0.003).
Next, we analyzed the postoperative outcome in well-
matched patients. Although, the operation time was longer 
in VE group (P=0.015), pulmonary complications occurred 







Sex (male) 40 (95.2) 126 (97.0) 0.605
Age (years) 63.3±7.7 65.6±7.6 0.083
BMI (kg/m
2
) 22.1±2.7 22.6±2.6 0.288
FEV1 predicted (%) 104.4±18.5 99.7±16.4 0.120
Charlson comorbidity index 0.387
2 26 (61.9) 65 (50.0)
3 13 (31.0) 55 (42.3)
4 3 (7.1) 10 (7.7)
Tumor location 0.036
Middle thoracic 30 (71.4) 69 (53.1)
Lower thoracic 12 (28.6) 61 (46.9)
Tumor type 0.672
Squamous cell carcinoma 39 (92.9) 123 (94.6)
Others 3 (7.1) 7 (5.4)
Tumor grade 0.424
Well differentiated 11 (26.2) 36 (27.7)
Moderate differentiated 26 (61.9) 68 (52.3)
Poorly differentiated 5 (11.9) 26 (20.0)
Pathologic T stage 0.023
1 28 (66.7) 55 (42.3)
2 3 (7.1) 16 (12.3)
3 11 (26.2) 59 (45.4)
Pathologic N stage 0.109
0 25 (59.5) 58 (44.6)
1 12 (28.6) 38 (29.2)
2 5 (11.9) 21 (16.2)
3 0 13 (10.0)
Operative methods 0.672
Ivor Lewis 35 (83.3) 105 (80.8)
McKeown 7 (16.7) 25 (19.2)
3-FD 4 (9.5) 27 (20.8) 0.099
Data were presented as number of patients (percentage) or mean 
± standard deviation. Data in parenthesis indicate percentage. VE, 
video-assisted thoracoscopic surgery esophagectomy; OE, open 
esophagectomy; BMI, body mass index; FEV1, forced expiratory 
in 1 second; 3-FD, 3-field dissection.
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more frequently in the OE group (9.5% vs. 40.5%, P=0.004). 
Regarding postoperative pneumonia, there were higher 
occurrences in the OE group than in the VE group (31.0% vs. 
7.1%, P=0.021; Table 4). In the OE group, compared with the 
VE group, there were greater occurrences of postoperative 
atelectasis needing bronchoalveolar toileting using flexible 
bronchoscopy (23.8% vs. 2.4%, P=0.012). The number 
of harvested lymph nodes was not significantly different 
between the two groups (31 vs. 33, P=0.198).
The median follow-up for the matched patients was 
29.3 months, the 2-year overall survival for the VE group 
and OE group was 74.4% and 76.9%, respectively (Figure 
2). There were no statistical differences between the two 
groups. The 2-year disease-free survival for the VE group 
and OE group was 69.5% and 68.8%, respectively. There 
were also no statistical differences between the two groups. 
Discussion
Recently, there has been much advancement in the 
multidisciplinary approaches to treating esophageal cancer. 
However, esophagectomy is still the mainstay treatment 
modality for resectable esophageal cancer, despite its 
high operative mortality and morbidity (2). Moreover, 
pulmonary complications, such as pneumonia, ARDS, and 
other respiratory complications, despite recent progress in 
anesthetic procedures and postoperative care, still remain 
to be the most adverse events following esophagectomy (3). 
These problems contribute to prolonged hospital stay, 
increased mortality, and higher cost of treatment (9). 
Variable factors, including patient age, comorbidities, 
postoperative pain, aspiration, postoperative atelectasis, and 
recurrent laryngeal nerve injury are involved in pulmonary 
complications after esophagectomy. Surgical technique has 
also been regarded as key factor responsible for pulmonary 
complications (10).
Since the first reported MIE using thoracoscopic 
esophagectomy in 1992, many groups have attempted and 
reported various methods for MIE (6). The increase in the 
popularity of MIE is a result of technical advancements and 
development of endoscopic equipment in thoracoscopic, 
laparoscopic and robotic surgeries, which are all available 
for esophagectomy as well as extended mediastinal 
lymphadenectomy (10). Theoretically, MIE should reduce 
morbidity and show similar long-term outcomes compared 
with OE. However, to the best of our knowledge, advantages 
regarding the oncologic outcomes, such as overall survival, 
disease-free survival, and number of harvested lymph nodes 
Table 2 Patients’ characteristics in the VE and OE groups after 
propensity score-matching
Variables VE (n=42) OE (n=42) P value
Sex (male) 40 (95.2) 39 (92.9) 0.665
Age (years) 63.3±7.7 64.3±7.2 0.577
BMI (kg/m
2
) 22.1±2.7 21.9±2.9 0.773




2 26 (61.9) 21 (50.0)
3 13 (31.0) 20 (47.6)
4 3 (7.1) 1 (2.4)
Tumor location 0.796
Middle thoracic 30 (71.4) 31 (73.8)




39 (92.9) 39 (92.9)
Others 3 (7.1) 3 (7.1)
Tumor grade 0.496
Well differentiated 11 (26.2) 12 (28.6)
Moderate 
differentiated
26 (61.9) 28 (66.7)
Poorly differentiated 5 (11.9) 2 (4.8)
Pathologic T stage 0.914
1 28 (66.7) 29 (69.0)
2 3 (7.1) 2 (4.8)
3 11 (26.2) 11 (26.2)
Pathologic N stage 0.870
0 25 (59.5) 25 (59.5)
1 12 (28.6) 13 (31.0)
2 5 (11.9) 4 (9.5)
Operative method 1.000
Ivor Lewis 35 (83.3) 35 (83.3)
McKeown 7 (16.7) 7 (16.7)
3-FD 4 (9.5) 7 (16.7) 0.366
Data were presented as number of patients (percentage) or mean 
± standard deviation. Data in parenthesis indicate percentage. VE, 
video-assisted thoracoscopic surgery esophagectomy; OE, open 
esophagectomy; BMI, body mass index; FEV1, forced expiratory 
in 1 second; 3-FD, 3-field dissection.
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using MIE have not been fully established (11). 
In this study, we showed that VE compared with OE 
was associated with lower postoperative overall pulmonary 
complications, lower postoperative atelectasis and lower 
postoperative pneumonia in a study population of well-
matched esophageal cancer patients. Our overall incidence 
of pulmonary complications and pneumonia in OE was 
comparable with that of other previous studies (5). The 
number of harvested lymph nodes was not significantly 
different (31 vs. 33, P=0.198) between the two groups, 
satisfying the requirements for the Worldwide Esophageal 
Cancer Collaboration data (12,13). Lagerson and colleagues 
suggested that a higher number of harvested lymph nodes 
provided better survival in esophageal cancer (2). Many 
surgeons believe that MIE is inappropriate in obtaining 
adequate lymph node harvesting and that insufficient 
lymph node harvesting leads to a lower incidence of 
pulmonary complication outcomes. Extended lymph node 
dissection was assumed to increase the risk of pulmonary 
complications. However, in our present study, harvesting an 
adequate number of lymph nodes was achieved by VE. We 
were able to compare the optimal method between VE and 
OE using a propensity score-matched analysis. 
Many studies have previously reported methods to 
significantly lower the complications in MIE with prone 
position. Palanivelu and colleagues demonstrated that 2.3% 
pulmonary complications occurred in their MIE group with 
prone-position (7). They suggested that the prone position 
provided several benefits, including a good operative field 
of the mid-to-lower mediastinum without any retraction of 
the right lung, shorter operative time, and lower incidence 
of pulmonary complications compared with the lateral 
decubitus position (14,15). Concurrently, however, the 
prone position also has disadvantages. It is vulnerable to 
urgent thoracotomy conversion in the event of emergency 
situations like massive bleeding. In our present study, the 
Table 3 Postoperative outcomes of propensity score-unmatched and matched patients
Postoperative outcomes
Unadjusted Propensity score-matched
VE (n=42) OE (n=130) P value VE (n=42) OE (n=42) P value
Operative mortality [n (%)] 0 5 (3.8) 0.197 0 2 (4.8) 0.157
Operation time [range] (min) 330 [235–595] 310 [180–640] 0.025 330 [235–595] 298 [180–455] 0.015
ICU stay [range] (days) 1 [1–5] 1 [1–157] 0.175 1 [1–5] 1 [1–157] 0.143
Blood loss [range] (mL) 200 [100–1,400] 300 [50–1,350] 0.055 200 [100–1,400] 300 [70–1,350] 0.297
Number of harvested LNs [range] 31 [7–71] 38 [7–127] 0.003 31 [7–71] 33 [7–81] 0.198
Overall complication (at least one) [n (%)]  16 (38.1) 62 (47.7) 0.277 16 (38.1) 24 (57.1) 0.088
Recurrent laryngeal nerve injury 8 (19.0) 19 (14.6) 0.492 8 (19.0) 7 (16.7) 0.782
Pulmonary complication 4 (9.5) 38 (29.2) 0.010 4 (9.5) 17 (40.5) 0.004
Arrhythmia 1 (2.4) 3 (2.3) 0.978 1 (2.4) 1 (2.4) 1.000
Anastomotic leak 2 (4.8) 11 (8.5) 0.430 2 (4.8) 4 (9.5) 0.414
Chylothorax 1 (2.4) 5 (3.8) 0.653 1 (2.4) 2 (4.8) 0.564
Postoperative bleeding 2 (4.8) 1 (0.8) 0.086 2 (4.8) 1 (2.4) 0.360
VE, video-assisted thoracoscopic surgery esophagectomy; OE, open esophagectomy; ICU, intensive care unit; LNs, lymph nodes.
Table 4 Postoperative pulmonary complications between VE and 
OE [n (%)]
Variables VE (n=42) OE (n=42) P value
Pulmonary complications 
(all)
4 (9.5) 17 (40.5) 0.004
Atelectasis 1 (2.4) 10 (23.8) 0.012
Pneumonia 3 (7.1) 13 (31.0) 0.021
Pneumonia (medication) 1 (2.4) 7 (16.7) 0.070
Pneumonia (ICU care) 2 (4.8) 6 (14.3) 0.289
ALI or ARDS 1 (2.4) 5 (11.9) 0.219
VE, video-assisted thoracoscopic surgery esophagectomy; 
OE, open esophagectomy; ALI, acute lung injury; ARDS, acute 
respiratory distress syndrome; ICU, intensive care unit.
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same method of esophagectomy in the left lateral decubitus 
position with a double lumen endotracheal tube was 
performed, regardless whether it was VE or OE, since this 
particular method was the most familiar method for thoracic 
surgeons. Considering the pulmonary complications of 
VE, although a precise comparison may be difficult, the left 
lateral decubitus position technique does not seem to be 
inferior to the prone position technique (15,16).
There are numerous types of MIE, depending on the 
approach—thoracic or abdominal. Total MIE uses both 
laparoscope and thoracoscope, while hybrid MIE uses only 
one of two (11). In our study, we used hybrid MIE; for 
the thoracic approach, we used thoracoscope and for the 
abdominal approach, we used an upper median laparotomy. 
Hybrid MIE using the thoracic approach was chosen because 
(I) most thoracic surgeons are more familiar with VATS, 
lacking the appropriate experience of using a laparoscope, and 
(II) cooperation with a general surgeon is made particularly 
difficult due to insurance complexities in Korea. Moreover, 
we believed that hybrid MIE using laparoscope, compared 
with hybrid MIE using thoracoscope, would result in higher 
pulmonary complications. Given such concerns, we decided 
to perform hybrid MIE using thoracoscope. Compared with 
the study by Glatz and colleagues, who used hybrid MIE with 
laparoscope, our study showed a greater number of harvested 
lymph node and a notably lower number of pulmonary 
complications (17). 
Generally, VE is known to have several advantages over 
OE, such as better cosmetic outcome with less incisions, 
less tissue trauma, less pain, reduced postoperative 
inflammatory responses, less morbidity, and early return to 
daily activities (18). All these advantages are strongly related 
to avoiding thoracotomy. As such, VE has been gaining 
increasing popularity among thoracic surgeons. Given that 
VE showed satisfying lymph node harvesting and minimal 
pulmonary complications, with similar mid-term results to 
that of OE, VE appears to have merit with respect to its 
efficacy and safety. However, the oncological benefits to 
patients undergoing VE have not been firmly established 
because there have been no randomized controlled trails 
verifying the equivalency in long-term survival of patients 
with VE compared with that in patients with OE (11). If 
many prospective studies indicate the oncological benefits 
of VE, VE could become one of the acceptable options for 
patients with esophageal cancer. 
This retrospective study has several limitations. First, our 
analysis included only a single institutional data, therefore, 
selection bias was inevitable. However, the propensity score-
matching carried out in this study likely provides the power 
to represent. Second, in terms of a propensity score-matched 
analysis, we were only able to use FEV1 as a preoperative 
factor for pulmonary function. Diffusing capacity of the lung 
for carbon monoxide (DLCO), which is another important 
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Figure 2 Overall survival and disease-free survival between matched 
VE and OE groups. VE, video-assisted thoracoscopic surgery 
esophagectomy; OE, open esophagectomy; OS, overall survival; 
DFS, disease-free survival; MIE, minimally invasive esophagectomy.
3012 Moon et al. Clinical outcomes of VATS esophagectomy
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(9):3005-3012jtd.amegroups.com
added in the inclusion criteria. Our data would have been 
more reliable if we had added both of these two factors.
Our findings also conclusively revealed that VE could be 
a feasible and safe method in both the short- and mid-term 
outcomes, equivalent to OE. Considering the postoperative 
pulmonary complications, VE is more beneficial than OE in 
selective patients. VE could become one of the acceptable 
options for patients with esophageal cancer. 
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